Predicting hospital readmissions in patients receiving novel-dose Sacubitril/Valsartan therapy: A competing-risk, causal mediation analysis
Changchun Hou, Xinxin Hao, Ning Sun, Xiaolin Luo, Luyu Wang, Enpu Yang, Zhichun Gao, Ling Chen, Zebi Wang, Yun Cui, Jing Zhong, Juhao Yang, Xi Liu, Zhexue Qin
doi: https://doi.org/10.1101/2023.02.08.23285680
Changchun Hou
1Department of Cardiology, Xinqiao Hospital, Army Medical University, Chongqing 400037, China
BScXinxin Hao
2Clinical Research Center, Xinqiao Hospital, Army Medical University, Chongqing 400037, China
MD, PhDNing Sun
1Department of Cardiology, Xinqiao Hospital, Army Medical University, Chongqing 400037, China
BScXiaolin Luo
1Department of Cardiology, Xinqiao Hospital, Army Medical University, Chongqing 400037, China
MD, PhDLuyu Wang
1Department of Cardiology, Xinqiao Hospital, Army Medical University, Chongqing 400037, China
BScEnpu Yang
1Department of Cardiology, Xinqiao Hospital, Army Medical University, Chongqing 400037, China
BScZhichun Gao
1Department of Cardiology, Xinqiao Hospital, Army Medical University, Chongqing 400037, China
MDLing Chen
1Department of Cardiology, Xinqiao Hospital, Army Medical University, Chongqing 400037, China
BScZebi Wang
1Department of Cardiology, Xinqiao Hospital, Army Medical University, Chongqing 400037, China
BScYun Cui
1Department of Cardiology, Xinqiao Hospital, Army Medical University, Chongqing 400037, China
BScJing Zhong
1Department of Cardiology, Xinqiao Hospital, Army Medical University, Chongqing 400037, China
BScJuhao Yang
3Department of Clinical Laboratory, Xinqiao Hospital, Army Medical University, Chongqing 400037, China
MDXi Liu
1Department of Cardiology, Xinqiao Hospital, Army Medical University, Chongqing 400037, China
MDZhexue Qin
1Department of Cardiology, Xinqiao Hospital, Army Medical University, Chongqing 400037, China
MD, PhDData Availability
Data not available due to ethical restrictions.
Posted February 10, 2023.
Predicting hospital readmissions in patients receiving novel-dose Sacubitril/Valsartan therapy: A competing-risk, causal mediation analysis
Changchun Hou, Xinxin Hao, Ning Sun, Xiaolin Luo, Luyu Wang, Enpu Yang, Zhichun Gao, Ling Chen, Zebi Wang, Yun Cui, Jing Zhong, Juhao Yang, Xi Liu, Zhexue Qin
medRxiv 2023.02.08.23285680; doi: https://doi.org/10.1101/2023.02.08.23285680
Predicting hospital readmissions in patients receiving novel-dose Sacubitril/Valsartan therapy: A competing-risk, causal mediation analysis
Changchun Hou, Xinxin Hao, Ning Sun, Xiaolin Luo, Luyu Wang, Enpu Yang, Zhichun Gao, Ling Chen, Zebi Wang, Yun Cui, Jing Zhong, Juhao Yang, Xi Liu, Zhexue Qin
medRxiv 2023.02.08.23285680; doi: https://doi.org/10.1101/2023.02.08.23285680
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (710)
- Anesthesia (201)
- Cardiovascular Medicine (2944)
- Dermatology (249)
- Emergency Medicine (440)
- Epidemiology (12748)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4586)
- Geriatric Medicine (419)
- Health Economics (729)
- Health Informatics (2918)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (426)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4358)
- Nursing (236)
- Nutrition (639)
- Oncology (2270)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6943)
- Radiology and Imaging (1529)
- Respiratory Medicine (915)
- Rheumatology (438)
- Sports Medicine (385)
- Surgery (489)
- Toxicology (60)
- Transplantation (212)
- Urology (181)